Dimethylformamide → HCID 54003210, compound

HRID 1791734Notes

Reaction equation

HRID 1791734 reaction equation
Cl[C:2]1[C:11]2[C:6](=[CH:7][C:8]([O:14][CH2:15][CH:16]3[CH2:21][CH2:20][N:19](CC#N)[CH2:18][CH2:17]3)=[C:9]([O:12][CH3:13])[CH:10]=2)[N:5]=[CH:4][N:3]=1.[OH:25][C:26]1[CH:27]=[C:28]2[C:32](=[CH:33][CH:34]=1)[NH:31][CH:30]=[CH:29]2.[C:35](=O)([O-])[O-].[Cs+].[Cs+].C[N:42]([CH:44]=O)C>>[C:44]([CH2:35][CH:15]([CH:16]1[CH2:17][CH2:18][NH:19][CH2:20][CH2:21]1)[O:14][C:8]1[CH:7]=[C:6]2[C:11]([C:2]([O:25][C:26]3[CH:27]=[C:28]4[C:32](=[CH:33][CH:34]=3)[NH:31][CH:30]=[CH:29]4)=[N:3][CH:4]=[N:5]2)=[CH:10][C:9]=1[O:12][CH3:13])#[N:42]

Participants

5

Conditions

Temperature
90 °C

Procedure

A solution of 4-chloro-6-methoxy-7-((1-cyanomethylpiperidin-4-yl)methoxy)quinazoline (200 mg, 0.58 mmol) and 5-hydroxyindole (85 mg, 0.63 mmol) in DMF (3 ml) containing cesium carbonate (282 mg, 0.86 mmol) was stirred at 90° C. for 90 minutes. After cooling, the mixture was poured onto water (25 ml). The precipitate was filtered, dried under vacuum and purified by reverse phase column chromatography on silica (kromasil® C18) eluting with methanol/water (1% acetic acid) (1/1). The fractions containing the expected product were combined and evaporated to give 7-((1-cyanomethyl)piperidin-4-ylmethoxy)-4-(indol-5-yloxy)-6-methoxyquinazoline (44 mg, 17%).

Workup

  1. temperatureAfter cooling
  2. additionthe mixture was poured onto water (25 ml)
  3. filtrationThe precipitate was filtered
  4. customdried under vacuum
  5. custompurified by reverse phase column chromatography on silica (kromasil® C18)
  6. washeluting with methanol/water (1% acetic acid) (1/1)
  7. additionThe fractions containing the expected product
  8. customevaporated

Sources & evidence

ORD record
ord-f444de9a91244262b159c3de8c35d021
Source dataset
uspto-grants-2006_07
Patent number
US07074800B1

Reaction notes

Loading…